세포 분리 시장 규모, 점유율, 성장 분석 : 제품 유형별, 세포 유형별, 세포원별, 기술별, 용도별, 지역별 - 업계 예측(2026-2033년)

Cell Isolation Market size was valued at USD 5.35 Billion in 2024 and is poised to grow from USD 6.03 Billion in 2025 to USD 15.81 Billion by 2033, growing at a CAGR of 12.8% during the forecast period (2026-2033).

Cell isolation is pivotal across a spectrum of applications, including biologics development, therapeutic protein synthesis, and research analysis. As healthcare costs rise due to chronic diseases, coupled with government initiatives aimed at boosting biotechnology, the demand for advanced cell isolation techniques is surging. Companies like NanoString Technologies, Levitas Bio, and Bionano Genomics have expanded their manufacturing processes and product lines to meet this demand. Recent innovations allow for the selection of high-performing cells for targeted applications, enhancing research outcomes. The rise of biopharmaceuticals and increased focus on healthcare innovation further drive the need for advanced cell isolation equipment, reflecting a growing trend in the market that seeks to optimize research and treatment methodologies. This trend indicates a robust opportunity for growth within the sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cell Isolation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cell Isolation Market Segments Analysis

Global Cell Isolation Market is segmented by Product, Cell Type, Cell Source, Technique, Application, End User, and region. Based on Product, the market is segmented into Consumables, and Instruments. Based on Cell Type, the market is segmented into Human Cells, and Animal Cells. Based on Cell Source, the market is segmented into Adipose Tissue, Bone Marrow, Cord Blood/Embryonic Stem Cells, and Other Cell Sources. Based on Technique, the market is segmented into Centrifugation-Based Cell Isolation, Surface Marker-Based Cell Isolation, and Filtration-Based Cell Isolation. Based on Application, the market is segmented into Biomolecule Isolation, Cancer Research,Stem CellResearch, Tissue, Regeneration & Regenerative Medicine, In Vitro Diagnostics, and Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Laboratories, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Cell Isolation Market

The cell isolation market is significantly driven by the rising incidence of chronic diseases, particularly cancer. As cancer rates escalate globally, the need for innovative research and treatment solutions intensifies. Cell isolation is crucial in cancer research, allowing scientists to examine distinct cell types, which facilitates the creation of targeted therapies and personalized medicine. By isolating cells, researchers gain vital insights into tumor biology, drug resistance, and immune responses, leading to the design of more effective treatments. Additionally, the growing demand for advanced therapies, including immunotherapy, further fuels the need for cell isolation techniques, driving growth and innovation across research institutions, biotech firms, and pharmaceutical companies.

Restraints in the Cell Isolation Market

One of the primary challenges facing the cell isolation market is the significant financial investment required for the specialized equipment and technologies necessary for isolating specific cell types. The high costs associated with advanced tools like flow cytometers, centrifuges, and magnetic-activated cell sorting (MACS) systems can deter many small research institutions and laboratories from acquiring them. Additionally, the ongoing expenses for reagents and the need for highly trained personnel further contribute to the overall financial strain, which may hinder the adoption of sophisticated cell isolation methods and limit research and development opportunities in this field.

Market Trends of the Cell Isolation Market

The cell isolation market is witnessing a significant shift towards the large-scale application of microfluidics technology, characterized by the manipulation of tiny fluid volumes through microchannels. This innovative approach allows for the precise separation of cells based on distinct characteristics such as size and shape, enhancing the isolation of rare cell types from complex biological matrices, including circulating tumor cells and stem cells. The advantages of microfluidics, including improved accuracy and efficiency, coupled with reduced reagent consumption and cost-effectiveness, position it as a highly attractive solution for both research and clinical applications, thereby driving its adoption across the healthcare and biotechnology sectors.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Technology Analysis
• Pricing Analysis
• Value Chain Analysis
• Patent Analysis
• Supply Chain Analysis
• Regulatory Landscape
• Customer & Buying Criteria Analysis

Cell Isolation Market by Product

• Market Overview
• Consumables
  • Reagents, Kits, Media, And Sera
  • Beads
  • Magnetic Beads
  • Fluorescent Beads
  • Disposables
• Instruments
  • Centrifuges
  • Cell Sorters
  • Magnetic-Activated Cell Separator Systems
  • Filtration Systems

Cell Isolation Market by Cell Type

• Market Overview
• Human Cells
  • Differentiated Cells
  • Stem Cells
• Animal Cells

Cell Isolation Market by Cell Source

• Market Overview
• Adipose Tissue
• Bone Marrow
• Cord Blood/Embryonic Stem Cells
• Other Cell Sources

Cell Isolation Market by Technique

• Market Overview
• Centrifugation-Based Cell Isolation
• Surface Marker-Based Cell Isolation
• Filtration-Based Cell Isolation

Cell Isolation Market by Application

• Market Overview
• Biomolecule Isolation
• Cancer Research
• Stem Cell Research
• Tissue Regeneration & Regenerative Medicine
• In Vitro Diagnostics
• Other Applications

Cell Isolation Market by End User

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Hospitals & Diagnostic Laboratories
• Other End Users

Cell Isolation Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2025

Key Company Profiles

• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGAA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genscript (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Standard Biotools (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alfa Laval (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Micareo Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Applied Cells Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stemcell Technologies (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Bioarray (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Proteintech Group, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Magbio Genomics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Akadeum Life Sciences (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pluriselect Life Science Ug (Haftungsbeschrankt) & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Invent Biotechnologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments